Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus ‘Moderate Buy’ Rating from Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) has been assigned a consensus rating of “moderate buy” by the ten analysts who currently cover the stock, Marketbeat reports. One investment analyst rated the stock with a sell recommendation, two gave the company a hold recommendation, four gave the company a buy recommendation and one gave the company a strong buy recommendation. The 1-year average price target among brokers who have reported on the stock in the past year is $5.30.

AVAH has been the subject of several research reports. Truist Financial downgraded Aveanna Healthcare from a “buy” rating to a “hold” rating and set a price target of $2.50 for the company. in a report on Tuesday July 5. Barclays cut its price target on Aveanna Healthcare from $7.00 to $5.00 and set an “overweight” rating for the company in a Friday, August 19 report. Jefferies Financial Group downgraded Aveanna Healthcare from a “buy” rating to a “hold” rating and set a price target of $2.50 for the company. in a report on Friday, July 22. Bank of America downgraded Aveanna Healthcare from a “neutral” rating to an “underperforming” rating and reduced its price target for the company from $3.00 to $2.00 in a Tuesday, June 21 report. Finally, Raymond James cut his price target on Aveanna Healthcare from $8.00 to $6.00 and set a “Strong Buy” rating for the company in a Monday, August 15 report.

Aveanna Healthcare Stock Performance

A d behind the markets

WARNING: Your download link will expire

If you still haven’t read our free report, “‘Cut & Paste’ – Small Business Revolutionizing Medicine”… …please take a few seconds to check it out before the report link expires.

Shares of AVAH opened at $2.02 on Friday. The stock has a fifty-day moving average of $2.13 and a 200-day moving average of $3.04. Aveanna Healthcare has a 52 week minimum of $1.66 and a 52 week maximum of $9.19. The company has a market capitalization of $375.56 million, a price-earnings ratio of -0.65 and a beta of 1.03. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt ratio of 6.19.

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last released its quarterly earnings data on Wednesday, August 10. The company reported earnings per share (EPS) of $0.03 for the quarter, missing analyst consensus estimates of $0.06 per ($0.03). Aveanna Healthcare posted a positive return on equity of 9.57% and a negative net margin of 33.32%. In the same period a year earlier, the company posted earnings per share of $0.08. As a group, research analysts expect Aveanna Healthcare to post earnings per share of 0.16 for the current year.

Institutional investors weigh in on Aveanna Healthcare

Several institutional investors have recently changed their stake in AVAH. Nut Tree Capital Management LP increased its position in Aveanna Healthcare by 40.2% in the fourth quarter. Nut Tree Capital Management LP now owns 5,435,479 shares of the company worth $40,223,000 after purchasing an additional 1,557,591 shares in the last quarter. Westwood Holdings Group Inc. increased its position in Aveanna Healthcare by 24.9% in the fourth quarter. Westwood Holdings Group Inc. now owns 4,163,789 shares of the company worth $30,812,000 after purchasing an additional 829,270 shares in the last quarter. Littlejohn & Co. LLC increased its position in Aveanna Healthcare by 12.4% in the second quarter. Littlejohn & Co. LLC now owns 3,895,001 shares of the company worth $8,803,000 after purchasing an additional 429,900 shares in the last quarter. Principal Financial Group Inc. increased its position in Aveanna Healthcare by 27.7% in the second quarter. Principal Financial Group Inc. now owns 3,137,855 shares of the company worth $7,091,000 after purchasing an additional 680,016 shares in the last quarter. Finally, BlackRock Inc. increased its position in Aveanna Healthcare by 2.3% in the first quarter. BlackRock Inc. now owns 3,087,209 shares of the company worth $10,526,000 after purchasing an additional 69,609 shares in the last quarter. 92.00% of the shares are held by hedge funds and other institutional investors.

About Aveanna Healthcare

(Get a rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private nursing (PDN), adult healthcare and palliative care, pediatric home therapy and enteral nutrition services in the States -United. Its patient-centric care delivery platform allows patients to stay at home and minimizes overuse of high-cost care facilities, such as hospitals.

Featured articles

Analyst Recommendations for Aveanna Healthcare (NASDAQ: AVAH)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Aveanna Healthcare, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Aveanna Healthcare didn’t make the list.

Although Aveanna Healthcare currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

About Tina G.

Check Also

FLEX LNG Ltd. (NYSE: FLNG) Receives Average “Holding” Recommendation From Brokerages

FLEX LNG Ltd. (NYSE:FLNG – Get Rating) has been assigned a consensus recommendation of “Hold” …